{"id":"https://openalex.org/W2606487392","doi":"https://doi.org/10.1016/j.critrevonc.2017.03.032","title":"Management of adverse events during treatment of gastrointestinal cancers with epidermal growth factor inhibitors","display_name":"Management of adverse events during treatment of gastrointestinal cancers with epidermal growth factor inhibitors","alternate_titles":[],"publication_year":2017,"publication_date":"2017-04-11","ids":{"openalex":"https://openalex.org/W2606487392","doi":"https://doi.org/10.1016/j.critrevonc.2017.03.032","mag":"2606487392","pmid":"https://pubmed.ncbi.nlm.nih.gov/28477738"},"language":"en","primary_location":{"id":"doi:10.1016/j.critrevonc.2017.03.032","doi":"https://doi.org/10.1016/j.critrevonc.2017.03.032","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2017.03.032","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1040842816303869/pdf","source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2606487392"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S1040842816303869/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052177007","display_name":"Ralf\u2010Dieter Hofheinz","orcid":"https://orcid.org/0000-0001-5972-8504","observed_orcids":["https://orcid.org/0000-0001-5972-8504"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4387153978","display_name":"Medizinische Fakult\u00e4t Mannheim","ror":"https://ror.org/02m1z0a87","country_code":"DE","type":"education","lineage":["https://openalex.org/I4387153978"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ralf-Dieter Hofheinz","raw_affiliation_strings":["Interdisziplin\u00e4res Tumorzentrum Mannheim, Universit\u00e4tsmedizin Mannheim, Universit\u00e4t Heidelberg, Germany. Electronic address: Ralf-Dieter.Hofheinz@medma.uni-heidelberg.de","Interdisziplin\u00e4res Tumorzentrum Mannheim, Universit\u00e4tsmedizin Mannheim, Universit\u00e4t Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Interdisziplin\u00e4res Tumorzentrum Mannheim, Universit\u00e4tsmedizin Mannheim, Universit\u00e4t Heidelberg, Germany. Electronic address: Ralf-Dieter.Hofheinz@medma.uni-heidelberg.de","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4387153978"]},{"raw_affiliation_string":"Interdisziplin\u00e4res Tumorzentrum Mannheim, Universit\u00e4tsmedizin Mannheim, Universit\u00e4t Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069983847","display_name":"Siegfried Segaert","orcid":"https://orcid.org/0000-0003-0708-7279","observed_orcids":["https://orcid.org/0000-0003-0708-7279"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Siegfried Segaert","raw_affiliation_strings":["Dermatology Department, University Hospital Sint-Rafa\u00ebl, Leuven, Belgium. Electronic address: siegfried.segaert@kuleuven.be","Dermatology Department, University Hospital Sint-Rafa\u00ebl, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department, University Hospital Sint-Rafa\u00ebl, Leuven, Belgium. Electronic address: siegfried.segaert@kuleuven.be","institution_ids":["https://openalex.org/I2800231306"]},{"raw_affiliation_string":"Dermatology Department, University Hospital Sint-Rafa\u00ebl, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019511410","display_name":"Mar\u00eda Jos\u00e9 Safont","orcid":"https://orcid.org/0000-0003-4584-0452","observed_orcids":["https://orcid.org/0000-0003-4584-0452"]},"institutions":[{"id":"https://openalex.org/I4210127649","display_name":"Hospital General Universitario De Valencia","ror":"https://ror.org/03sz8rb35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210127649"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mar\u00eda Jos\u00e9 Safont","raw_affiliation_strings":["General Universitary Hospital of Valencia, Valencia, Spain. Electronic address: mjsafont@yahoo.es","General Universitary Hospital of Valencia, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Universitary Hospital of Valencia, Valencia, Spain. Electronic address: mjsafont@yahoo.es","institution_ids":["https://openalex.org/I4210127649"]},{"raw_affiliation_string":"General Universitary Hospital of Valencia, Valencia, Spain","institution_ids":["https://openalex.org/I4210127649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001388674","display_name":"Gaston Demonty","orcid":"https://orcid.org/0000-0003-0626-9222","observed_orcids":["https://orcid.org/0000-0003-0626-9222"]},"institutions":[{"id":"https://openalex.org/I4210139000","display_name":"Amgen (Switzerland)","ror":"https://ror.org/045wjte67","country_code":"CH","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210139000"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gaston Demonty","raw_affiliation_strings":["Medical Development, Amgen (Europe) GmbH, Zug, Switzerland. Electronic address: gdemonty@amgen.com","Medical Development, Amgen (Europe) GmbH, Zug, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Development, Amgen (Europe) GmbH, Zug, Switzerland. Electronic address: gdemonty@amgen.com","institution_ids":["https://openalex.org/I4210139000"]},{"raw_affiliation_string":"Medical Development, Amgen (Europe) GmbH, Zug, Switzerland","institution_ids":["https://openalex.org/I4210139000"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060176567","display_name":"Hans Prenen","orcid":"https://orcid.org/0000-0001-8802-7352","observed_orcids":["https://orcid.org/0000-0001-8802-7352"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hans Prenen","raw_affiliation_strings":["Digestive Oncology Unit, UZ Leuven, Leuven, Belgium. Electronic address: hans.prenen@uzleuven.be","Digestive Oncology Unit, UZ Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Digestive Oncology Unit, UZ Leuven, Leuven, Belgium. Electronic address: hans.prenen@uzleuven.be","institution_ids":["https://openalex.org/I2800231306"]},{"raw_affiliation_string":"Digestive Oncology Unit, UZ Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5052177007"],"corresponding_institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4387153978"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":{"value":4190,"currency":"USD","value_usd":4190},"fwci":0.6356,"has_fulltext":true,"cited_by_count":47,"citation_normalized_percentile":{"value":0.57781293,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"114","issue":null,"first_page":"102","last_page":"113"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.4542999863624573,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.4542999863624573,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.3732999861240387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.11159999668598175,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.8859999775886536},{"id":"https://openalex.org/keywords/gastrointestinal-cancer","display_name":"gastrointestinal cancer","score":0.9020000100135803},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.7630000114440918},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5450000166893005},{"id":"https://openalex.org/keywords/papulopustular-rash","display_name":"papulopustular rash","score":0.8610000014305115},{"id":"https://openalex.org/keywords/mucosal-toxicity","display_name":"mucosal toxicity","score":0.7940000295639038},{"id":"https://openalex.org/keywords/hypomagnesemia","display_name":"hypomagnesemia","score":0.9760000109672546},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.906000018119812},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.8759999871253967},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.9599999785423279},{"id":"https://openalex.org/keywords/prophylaxis","display_name":"prophylaxis","score":0.7900000214576721},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8519999980926514},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8610000014305115},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7577260732650757},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.7522531151771545},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.6416513323783875},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6362555623054504},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5680189728736877},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5525642037391663},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4919297695159912},{"id":"https://openalex.org/C542804219","wikidata":"https://www.wikidata.org/wiki/Q5526839","display_name":"Gastrointestinal cancer","level":4,"score":0.4572983682155609},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.44628873467445374},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43387627601623535},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4293774962425232},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.4290744662284851},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4218074083328247},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4045007824897766},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39264997839927673},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3276922404766083},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13801082968711853}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005770","descriptor_name":"Gastrointestinal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019468","descriptor_name":"Disease Management","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.critrevonc.2017.03.032","doi":"https://doi.org/10.1016/j.critrevonc.2017.03.032","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2017.03.032","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1040842816303869/pdf","source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},{"id":"pmid:28477738","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28477738","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical reviews in oncology/hematology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.critrevonc.2017.03.032","doi":"https://doi.org/10.1016/j.critrevonc.2017.03.032","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2017.03.032","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1040842816303869/pdf","source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2606487392.pdf","grobid_xml":"https://content.openalex.org/works/W2606487392.grobid-xml"},"referenced_works_count":103,"referenced_works":["https://openalex.org/W74611304","https://openalex.org/W109492528","https://openalex.org/W116685234","https://openalex.org/W169630847","https://openalex.org/W203783494","https://openalex.org/W1499416822","https://openalex.org/W1804059878","https://openalex.org/W1825445477","https://openalex.org/W1896254854","https://openalex.org/W1949714558","https://openalex.org/W1973982291","https://openalex.org/W1975209104","https://openalex.org/W1975747597","https://openalex.org/W1978860812","https://openalex.org/W1980070091","https://openalex.org/W1984047229","https://openalex.org/W1986364417","https://openalex.org/W1991250961","https://openalex.org/W1994460482","https://openalex.org/W2000768707","https://openalex.org/W2002226820","https://openalex.org/W2005348280","https://openalex.org/W2007276849","https://openalex.org/W2008271829","https://openalex.org/W2008322008","https://openalex.org/W2009000810","https://openalex.org/W2011513069","https://openalex.org/W2015448535","https://openalex.org/W2028486975","https://openalex.org/W2045295020","https://openalex.org/W2047268479","https://openalex.org/W2049050498","https://openalex.org/W2049309222","https://openalex.org/W2056241214","https://openalex.org/W2057039211","https://openalex.org/W2060631221","https://openalex.org/W2060661695","https://openalex.org/W2062860758","https://openalex.org/W2070408009","https://openalex.org/W2077142615","https://openalex.org/W2095201384","https://openalex.org/W2096385798","https://openalex.org/W2097121246","https://openalex.org/W2098354753","https://openalex.org/W2102361940","https://openalex.org/W2102953577","https://openalex.org/W2104580737","https://openalex.org/W2104604860","https://openalex.org/W2108554229","https://openalex.org/W2110920272","https://openalex.org/W2114578638","https://openalex.org/W2115790682","https://openalex.org/W2115898240","https://openalex.org/W2117355364","https://openalex.org/W2118466253","https://openalex.org/W2120496760","https://openalex.org/W2120848693","https://openalex.org/W2124851771","https://openalex.org/W2129255527","https://openalex.org/W2132352600","https://openalex.org/W2136781635","https://openalex.org/W2138635576","https://openalex.org/W2140035322","https://openalex.org/W2141665958","https://openalex.org/W2144025124","https://openalex.org/W2144425748","https://openalex.org/W2145564580","https://openalex.org/W2149050045","https://openalex.org/W2150617926","https://openalex.org/W2152362765","https://openalex.org/W2156700619","https://openalex.org/W2158134441","https://openalex.org/W2158334747","https://openalex.org/W2160344439","https://openalex.org/W2161016520","https://openalex.org/W2161938839","https://openalex.org/W2162896805","https://openalex.org/W2163592822","https://openalex.org/W2164035913","https://openalex.org/W2165411051","https://openalex.org/W2165879808","https://openalex.org/W2166191933","https://openalex.org/W2166559675","https://openalex.org/W2168106806","https://openalex.org/W2169449140","https://openalex.org/W2172909145","https://openalex.org/W2197159080","https://openalex.org/W2201922795","https://openalex.org/W2219221010","https://openalex.org/W2266497836","https://openalex.org/W2301584429","https://openalex.org/W2316750470","https://openalex.org/W2336815607","https://openalex.org/W2337497883","https://openalex.org/W2340784104","https://openalex.org/W2341711326","https://openalex.org/W2346921980","https://openalex.org/W2406912655","https://openalex.org/W2409420104","https://openalex.org/W2415725664","https://openalex.org/W2504049772","https://openalex.org/W2591322065","https://openalex.org/W3190697283"],"related_works":["https://openalex.org/W2077950012","https://openalex.org/W2514659306","https://openalex.org/W2062860758","https://openalex.org/W2025662170","https://openalex.org/W2611599688","https://openalex.org/W3159941718","https://openalex.org/W2029591332","https://openalex.org/W1969936956"],"abstract_inverted_index":{"The":[0],"epidermal":[1],"growth":[2],"factor":[3],"receptor":[4],"(EGFR)":[5],"is":[6,17,84],"involved":[7],"in":[8,138],"development":[9],"and":[10,16,23,51,77,98,113,136,143,148],"progression":[11],"of":[12,90,100,116,123],"some":[13],"gastrointestinal":[14,141],"cancers,":[15,142],"targeted":[18],"by":[19],"monoclonal":[20],"antibodies":[21],"(mAbs)":[22],"tyrosine":[24],"kinase":[25],"inhibitors":[26],"(TKIs)":[27],"used":[28],"to":[29,110,120],"treat":[30],"these":[31,101],"conditions.":[32],"Targeted":[33],"agents":[34],"are":[35,55],"generally":[36],"better":[37],"tolerated":[38],"than":[39],"conventional":[40],"chemotherapy,":[41],"but":[42],"have":[43],"characteristic":[44],"toxicities":[45,59,69,131],"that":[46],"can":[47,103,118],"affect":[48],"adherence,":[49],"dosing,":[50],"outcomes.":[52],"Skin":[53],"conditions":[54],"the":[56,80,96,111,114,129],"most":[57],"common":[58,68],"associated":[60,86,132],"with":[61,87,133,140],"EGFR":[62],"inhibitors,":[63],"particularly":[64],"papulopustular":[65],"rash.":[66],"Other":[67],"include":[70],"mucosal":[71],"toxicity,":[72],"electrolyte":[73],"imbalances":[74],"(notably":[75],"hypomagnesaemia),":[76],"diarrhoea,":[78],"while":[79,106],"chimaeric":[81],"mAb":[82],"cetuximab":[83],"also":[85],"increased":[88],"risk":[89],"infusion":[91],"reactions.":[92],"With":[93],"appropriate":[94],"prophylaxis,":[95],"incidence":[97],"severity":[99],"events":[102],"be":[104],"reduced,":[105],"management":[107],"strategies":[108],"tailored":[109],"patient":[112],"degree":[115],"toxicity":[117],"help":[119],"ensure":[121],"continuation":[122],"anti-cancer":[124],"therapy.":[125],"Here,":[126],"we":[127],"review":[128],"main":[130],"EGFR-inhibiting":[134],"mAbs":[135],"TKIs":[137],"patients":[139],"provide":[144],"recommendations":[145],"for":[146],"prophylaxis":[147],"treatment.":[149]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2606487392","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-04-28T00:00:00"}
